Media Center

In a step that further strengthens Dubai’s global standing in advanced scientific research, a research team at Dubai Health has published a new scientific study in the international medical journal Nature Communications, revealing innovative techniques for the detection and diagnosis of rare diseases using genomic medicine.
The study, titled "Long Read Sequencing Enhances Pathogenic and Novel Variation Discovery in Patients with Rare Diseases," provides a scientific framework to improve the diagnostic accuracy of rare diseases. It demonstrates how advances in clinical genetic testing can increase precision and lead to more effective medical tools, directly supporting the healthcare system and Dubai Health’s Patient First commitment.
Dr. Rasha Buhumaid, Dean of the College of Medicine and Graduate Medical Education at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, said: “This success reflects our commitment to fostering scientific research within Dubai Health and our strategic partnership between academic inquiry and clinical practice. It is a purposeful step toward developing medical practices that enhance wellbeing and elevate the quality of patient care."
She added: “Fatma’s achievement demonstrates the strength of our graduate programs and the vibrant research culture across our academic health system. Through our Master’s and PhD programs in Biomedical Sciences, MBRU is dedicated to preparing research professionals equipped with rigorous scientific thinking and advanced research skills, fostering a discovery-based learning environment that supports sustainable development in healthcare. These research-intensive programs combine rigorous academic training with hands-on experience across Dubai Health’s clinical and research facilities. Students benefit from competitive financial support, including full scholarships for PhD candidates and substantial aid for Master’s students, enabling them to pursue high-impact research.”

Diagnostic Accuracy
Fatma Rabea, Emirati PhD student at MBRU, and spokesperson for the research team, explained that the study plays a key role in enhancing the accuracy of diagnosing rare diseases by using modern techniques to uncover their genetic origins. This approach supports evidence-based treatment decisions and helps elevate the standard of care for these patients, empowering them through precise diagnosis.
Fatma noted that the study analyzed clinical samples, demonstrating that long-read genomic sequencing techniques significantly improved diagnostic accuracy for rare diseases by identifying genetic variants missed by traditional methods. This led to new diagnoses for approximately 10% of the cases studied, providing essential treatments and enhancing wellbeing.
The Hamdan Medical Research Award
The study was honored with the prestigious Arab Award for Research in Healthcare, as part of the Hamdan bin Rashid Al Maktoum Foundation for Medical and Educational Sciences 2025 Medical Awards. This honor recognizes the meaningful contributions MBRU students make in advancing discovery and contributing to globally relevant research. This accolade recognizes the study's substantial scientific contribution to improving diagnostic precision for rare diseases, which directly enhances overall patient care. 
To access the study, visit https://www.nature.com/articles/s41467-025-57695-9.

Dubai Health and Johnson & Johnson MedTech have signed a Memorandum of Understanding (MoU) establishing a collaborative framework to advance professional education, drive sustainability initiatives, and support digital innovation in healthcare. 

The MoU was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and Prosun Niyogi, Vice President and General Manager, Surgery Emerging Markets representing Johnson & Johnson MedTech. The signing was attended by Dr. Tarek Fathey, Chief Clinical Officer at Dubai Health. 

The collaboration is structured around three core pillars. The first focuses on professional education and capacity building through tailored training programs and train-the-trainer initiatives. The second advances sustainable development by expanding recycling programs across selected hospitals. The third supports the implementation of digital ecosystems that enable surgical video capture, secure content sharing, collaborative case planning, and telepresence-enabled remote collaboration and education. 

Dr. Hanan Al Suwaidi said: “This strategic partnership with Johnson & Johnson MedTech reflects our commitment to healthcare excellence through purpose-driven partnerships. Guided by our vision to advance health for humanity, we are building a framework that will enhance professional education, promote sustainability, and support digital innovation across our integrated academic health system.” 

Dr. Tarek Fathey said: “This collaboration represents a significant milestone in advancing clinical practice across Dubai Health through the integration of advanced digital technologies into surgical environments and clinical education. It enhances precision in medical decision-making, strengthens multidisciplinary team capabilities, and ultimately contributes to improved patient outcomes.” 

Prosun Niyogi said, “Dubai Health's 'Patient First' promise reflects the same principle that guides everything we do at Johnson & Johnson MedTech: putting the needs of patients above all else. This partnership allows us to pioneer new models of professional education, advance sustainable healthcare practices, and connect clinicians through digital innovation- all in service of one goal: removing limitations to a full life and changing the trajectory of health for communities across the UAE and beyond.” 

The collaboration reflects a shared commitment to driving meaningful progress in healthcare through knowledge exchange, innovation, and strategic partnership, ultimately supporting better outcomes for patients and communities. 

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, launched ‘The Cancer Fund’ of Al Jalila Foundation, the philanthropic arm of Dubai Health, in the presence of His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors.

His Highness also unveiled ‘The Giving Wall’ at Dubai Hospital, which bears the names of donors who have supported its treatment programmes, in recognition of their generosity.

The Cancer Fund aims to provide vital support for cancer treatment, helping ease the financial burden on patients and ensuring they can continue their care throughout recovery.

The launch of The Cancer Fund took place during a ceremony hosted by Al Jalila Foundation at Dubai Hospital, where His Highness Sheikh Ahmed bin Saeed Al Maktoum honoured partners, donors, and supporters of the hospital’s treatment programmes.

The ceremony was attended by His Excellency Mohammed Ibrahim Al Shaibani, Director General of HH the Dubai Ruler's Court; Her Excellency Dr. Raja Easa Al Gurg, Member of Dubai Health Board of Directors, and Chairperson of Al Jalila Foundation Board of Directors; His Excellency Dr. Alawi AlSheikh-Ali, Director General of the Dubai Health Authority; His Excellency Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU); and other senior officials.

His Highness Sheikh Ahmed bin Saeed stated: “Giving is a deeply rooted value in the UAE instilled by our Founding Fathers and our leadership continues to build on this legacy through initiatives that place people’s health and wellbeing at the heart of national priorities.”

His Highness praised the individuals and institutions whose generosity strengthens community philanthropic efforts, noting that the strong engagement generated by such programmes reflects a shared national commitment to supporting people and enhancing quality of life.

Strategic step
Her Excellency Dr. Raja Easa Al Gurg said: “The Cancer Fund marks a strategic step towards building a sustainable support system for patients.”

She added: “The Fund also reflects a forward-looking model of collaboration, with community and institutional giving playing a central role in strengthening our healthcare system and expanding its impact on patients’ lives. We believe that sustainable philanthropy is essential to building a more cohesive society, where collective efforts come together to shape a better future for all.”

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Dedicating this year’s Ramadan campaign at Al Jalila Foundation to The Cancer Fund will expand support pathways available to cancer patients. It reflects the role of community giving in helping patients access timely treatment, in line with Dubai Health’s ‘Patient First’ promise.”

He added: “The generosity of donors enabled us to provide care to 650 cancer patients over the past year, with contributions exceeding AED43 million through the ‘A’awen’ programme.

Al Jalila Foundation encourages individuals and organisations to support the Ramadan 2026 campaign through its donation channels, emphasising that every contribution makes a difference for patients and their families by helping them access treatment.
 

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors, emphasised the importance of partnerships with leading academic health systems driven by scientific research and medical education to advance healthcare, elevate quality of care, strengthen patient safety standards, and build medical talent.
His Highness made these remarks during a meeting held on the sidelines of the World Health Expo (WHX) Dubai 2026, with Dr. Omar Lateef, President and CEO of Rush University System for Health and Rush University Medical Center, one of the world’s leading academic health systems. The meeting was attended by His Excellency Dr. Alawi AlSheikh-Ali, Director General of Dubai Health Authority, and His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences.
Rush University System for Health is ranked among the leading healthcare systems in the United States for quality, patient experience, and safety. It has received high ratings from patient safety regulators and is recognised for excellence across several medical specialties, including orthopedics, neurology, and cardiology.
One of the world’s leading healthcare exhibitions, WHX Dubai 2026 is taking place from 9 – 12 February at the Dubai Exhibition Centre (DEC).

Dubai Health Authority (DHA) and Dubai Health, represented by Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), have signed a Memorandum of Understanding (MoU) to advance the Emiratization of healthcare professions by supporting Emirati students enrolled in bachelor’s and master’s degree programs across various medical specializations at MBRU.
The MoU marks a significant step forward in a shared commitment to developing national healthcare talent. The signing ceremony was witnessed by His Excellency Dr. Alawi AlSheikh-Ali, Director General of Dubai Health Authority, and Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of MBRU.
Under the agreement, Dubai Health Authority will cover the tuition fees of a number of Emirati students enrolled in bachelor’s and master’s degree programs across various medical specializations at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, including programs offered by the Hind Bint Maktoum College of Nursing and Midwifery.
The MoU was signed by Dr. Asma Al Sharif, Acting CEO of the Health Regulation Sector at DHA, and Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of MBRU, during World Health Expo Dubai 2026. 
Dr. Asma Al Sharif said: “The MoU provides significant momentum to our shared efforts to advance the Emiratization of healthcare professions and equip the health sector with highly qualified national talent capable of achieving the strategic goals of Dubai’s health system.”

Dr. Hanan Al Suwaidi said: “This MoU reflects our commitment, together with Dubai Health Authority, to cultivating highly qualified national medical talent to lead the future of Dubai’s healthcare sector. By empowering Emirati students academically and professionally in vital specializations, including nursing, we strengthen the integration of our academic health system.”
She added: “The program will support students enrolled in the Medicine and Surgery programs, as well as those of the Hind Bint Maktoum College of Nursing and Midwifery at MBRU, reinforcing essential healthcare career pathways.”
 

Dubai Health has announced that its Ambulatory Health Centers, encompassing primary healthcare centers and outpatient specialized centers, as well as its hospitals have received accreditation from the Australian Council on Healthcare Standards International (ACHSI) during a celebration held at the Dubai Health stand at WHX Dubai.

The event was attended by H.E. Bryony Hilless, Consul General of Australia in Dubai and Northern Emirates; Mr. Mounir Sankary, Deputy Consul General and Trade and Investment Commissioner; H.E. Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences; Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences; Dr. Muna Tahlak, Chief Medical Officer of Dubai Health; Dr. Tarek Fathey, Chief Clinical Officer of Dubai Health; and Dr. Entesar Al Hammadi, Chief of Patient Safety and Quality at Dubai Health.

This achievement reflects Dubai Health’s commitment to implementing the highest global standards in healthcare services through initiatives designed to elevate both patient and employee experience. The ACHSI assessment leveraged results from the Press Ganey Patient Survey Program, alongside the “Dubai Health Majalis: Voice of the Community” initiative, which encouraged active community participation in shaping healthcare services. Feedback was also gathered through the 04 Platform, a unified communications channel that enables customers to submit suggestions, comments, and complaints.

Dr. Amer Sharif said: “Receiving accreditation from the Australian Council on Healthcare Standards International represents a significant step forward in our efforts to reinforce Dubai’s position as a global healthcare destination. It reflects our commitment to delivering high-quality, patient-centered care, in line with our broader vision to advance health for humanity.”

He added: “This achievement is a testament to the dedication of our teams, whose efforts continue to strengthen our integrated academic health system, guided by global best practices.”

Dr. Entesar AlHammadi, commented on this achievement saying: “Securing ACHSI accreditation is a key part of Dubai Health’s strategy to pursue international endorsements. It enables us to benchmark our centers against leading global healthcare systems, which supports the continuous advancement of our services, through initiatives that prioritize both patient and employee experience.”

Dr. AlHammadi confirmed that the accreditation encompasses Dubai Health’s Ambulatory Health Centers, including primary healthcare centers and outpatient specialized centers, as well as its hospitals, all of which met comprehensive standards covering patient and employee experience, clinical service quality, education and training, support services, infrastructure, and accessibility for people of determination.

She added: “Our centers are the first in the world to receive this accreditation within an integrated academic health system, demonstrating excellence across clinical care, education, research, and patient safety.”

A History of International Accreditation
The ACHSI accreditation adds to Dubai Health’s Joint Commission International (JCI) accreditation, reflecting continued alignment with global best practices.
The Australian Council on Healthcare Standards International is one of the world’s foremost healthcare accreditation bodies. It is an independent, non-profit organization dedicated to advancing the quality and safety of healthcare services worldwide.

Dubai Health has signed a Memorandum of Understanding (MoU) with the non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) at World Health Expo Dubai (WHX).

The agreement was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences, and Dr. Luis Pizarro, Executive Director of the Drugs for Neglected Diseases initiative (DNDi), in the presence of His Excellency Nicolas Niemtchinow, Ambassador of France to the UAE, and Thi Hanh Cao, Director of External Relations at DNDi.

The partnership establishes a framework for collaboration in medical education, research, and clinical training, with a shared goal of improving health outcomes for underserved populations affected by neglected infectious diseases. It brings together DNDi’s global expertise in needs‑driven drug discovery and development and Dubai Health’s integrated academic health system to support research and capacity‑building across priority global health areas.

Under the agreement, students from Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health will take part in DNDi‑led programs, including fieldwork and clinical research activities in Africa and Asia. These programs provide hands‑on exposure to patients affected by neglected diseases and to the full spectrum of drug discovery, development and public health delivery. DNDi experts will also contribute to MBRU academic programs, supporting two‑way academic and professional exchange.

The collaboration will begin with joint research scoping to identify priority projects. It will involve active faculty engagement through guest lectures, curriculum development, student co‑supervision, joint grant applications, and collaborative research publications.

The partnership will also encompass collaboration in drug discovery, clinical trials, regulatory science, and public health policy, with a particular focus on viral diseases, pandemic preparedness, and fungal infections. In addition, it will support joint initiatives in the application of artificial intelligence to health research, as well as the co‑organization of scientific conferences and workshops and the dissemination of knowledge on key global health challenges.

Dr. Luis Pizarro, said: “Neglected diseases disproportionately affect the world’s most vulnerable populations and are often overlooked by traditional research models. Through this partnership with Dubai Health, we aim to advance scientific progress while helping train the next generation of global health leaders to deliver more equitable health solutions.”

Dr. Hanan AlSuwaidi, said: “This partnership represents a meaningful step forward in how we prepare our students and researchers to engage with the world’s most pressing and complex health challenges. By partnering with DNDi, we are giving our learners direct access to real-world drug development, clinical research, and global health practice. It reflects our commitment to advancing health for humanity by ensuring that care, learning, discovery, and giving are driven by purpose and real-world impact.”

Dubai Health announced its participation in World Health Expo Dubai 2026 (WHX), where it will highlight the power of integrating care, learning, discovery, and giving to advance health for humanity. 

Through its participation, Dubai Health will demonstrate its evolution as an integrated academic health system, alongside the role of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, in developing talent and advancing medical education and scientific research. Al Jalila Foundation, the philanthropic arm of Dubai Health, will highlight the role of philanthropy in supporting healthcare.

At the stand, Dubai Health will offer immersive experiences for participants, featuring expert-led discussions and presentations on healthcare innovation, patient safety, digital transformation, and organ donation, among other topics, alongside a selection of research and clinical studies.

Organized by Informa Markets, WHX Dubai 2026 is a leading global platform for knowledge exchange and innovation in healthcare. The exhibition will take place from 9 to 12 February at Expo City Dubai, bringing together more than 4,800 exhibitors from over 180 countries, as well as international experts and thought leaders from across the sector.

Expanding Strategic Partnerships
Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences, said: “WHX Dubai 2026 provides a platform for Dubai Health to demonstrate the power of integration, bringing together care, learning, discovery, and giving. The exhibition also offers an opportunity to share global best practices in healthcare, with the participation of Dubai Health scientists and experts, while enabling dialogue and knowledge exchange with leading healthcare leaders from around the world.”
She noted that, during the exhibition, Dubai Health will expand its strategic partnerships with academic, research, and international partners through the signing of several memoranda of understanding. She added that Dubai Health will also highlight its academic and clinical partnerships, along with key international accreditations that reflect its commitment to meeting the highest global standards.

Reimagining the Patient Experience
Khalifa Baqer, Chief Operations Officer at Dubai Health, said: “Our participation in WHX Dubai 2026 highlights Dubai Health’s power of integration and its role in elevating the patient experience. This includes initiatives designed to improve access to care, alongside programs that encourage community involvement in shaping healthcare services and future development plans.”
He added: “As part of our commitment to social responsibility, a blood donation bus will be stationed at the exhibition throughout the event, offering visitors and participants the opportunity to donate blood and contribute to the wider community.”
Gala Dinner
Alongside the exhibition, Dubai Health Authority will host a private gala dinner in partnership with Dubai Health and Informa Markets, celebrating the Year of Family 2026 and recognizing the essential role families play in supporting healthcare professionals throughout their professional journeys.

The Board of Directors of Dubai Health convened its first meeting of the year, chaired by His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors. The meeting was attended by His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors.

The Board reviewed progress across Dubai’s integrated academic health system and discussed key strategic projects and future initiatives aimed at advancing healthcare excellence.

Held at the Dubai Health headquarters, the meeting was also attended by Her Excellency Dr. Raja Easa Al Gurg, His Excellency Abdulla Abdul Rahman Al Shaibani, Professor Sir Ian Andrew Greer, His Excellency Walid Saeed Al Awadhi, His Excellency Mohammed Hassan Al Shehhi, Dr. Amer Sharif, and Dr. Hanan Al Suwaidi.

His Highness Sheikh Ahmed bin Saeed Al Maktoum welcomed the Board members, noting their role in advancing Dubai’s health system and supporting the objectives of the Dubai Social Agenda 33, which aims to create a sustainable human-centered system. His Highness commended the achievements of Dubai Health teams and highlighted the importance of continued collaboration in driving progress that advances the quality of care and life for the community.

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum affirmed Dubai’s global position in healthcare, noting its continued progress in developing a system driven by knowledge, innovation, and professional excellence, and highlighting the role of Dubai Health as an integrated academic health system that brings together care, learning, discovery and giving to advance health for humanity.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, along with His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors, attended the graduation of the inaugural cohort of the Dubai Health Leadership Academy’s flagship Systems Leadership Program.
Delivered in partnership with the University of Oxford’s Saïd Business School, the Program celebrated the graduation of 40 graduates during a ceremony held at the Museum of The Future.

His Highness Sheikh Ahmed bin Saeed Al Maktoum congratulated the graduates, highlighting the importance of investing in leadership capabilities that can contribute to the development of the healthcare sector. “Guided by the vision of our leadership, Dubai is advancing the future of healthcare by developing leaders who can navigate rapid change and transform it into meaningful opportunities for growth and innovation,” he said. “I congratulate all the graduates whose leadership will shape the future of health in Dubai and advance the quality of care and life for our community,” His Highness added.

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, said “We are proud to celebrate the graduation of the first cohort of the Dubai Health Leadership Academy’s Systems Leadership Program, delivered in partnership with Saïd Business School at the University of Oxford. Building future-ready leaders remains central to our journey toward a sustainable health system, one built on knowledge, innovation and care, and informed by leading global practices.”

The ceremony was also attended by Her Excellency Dr. Raja Easa Al Gurg, Member of the Dubai Health Board of Directors, Chairperson of the Al Jalila Foundation Board of Directors, His Excellency Dr. Alawi Alsheikh-Ali, Director General of the Dubai Health Authority; His Excellency Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences; members of the Dubai Health Board of Directors; as well as Dr. Eleanor Murray, Academic Director and Senior Fellow in Management Practice at Oxford Saïd Business School, and Dr. Mark O’Brien, Program Director of the Systems Leadership Program and Associate Fellow at Oxford Saïd Business School.

His Excellency, Dr. Alawi Alsheikh-Ali, said: "The Systems Leadership Program stands as a powerful catalyst for transformation across our health system. It develops leaders who can navigate complexity, think holistically across the continuum of care, and champion the values at the heart of Dubai’s health sector. By strengthening the foundations of a resilient, people centered health system, we ensure excellence for our community today, while shaping a healthier, more sustainable future for our city and beyond."

His Excellency Dr. Amer Sharif, said: “This program was founded on the powerful idea that leadership in health must reflect the complexity and compassion of the system we serve. The Dubai Health Leadership Academy was designed with an ambitious purpose, to prepare leaders for a health system as dynamic as Dubai. Today our graduates are ready to carry that purpose forward.

He expressed his sincere gratitude to His Highness Sheikh Ahmed bin Saeed Al Maktoum and His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum for their support of the program, noting that the knowledge and experience gained by the graduates will be applied across the Dubai Health system.

He also thanked the program partners; Emirates, Dubai Airports, and the Mohammed Bin Rashid Space Centre, in recognition of their valuable contributions which elevated the program’s impact and continue to inspire Dubai Health’s transformation journey.

Commenting on the program, Dr. Eleanor Murray, said: “Witnessing this cohort reach graduation has been especially meaningful. The Systems Leadership Program brought together distinguished faculty and global experts who fostered thoughtful dialogue, encouraged reflection, and enriched participants’ understanding of leadership within complex health systems. Their Certificate of Completion, jointly endorsed by Dubai Health and Saïd Business School, formally recognises the comprehensive learning journey they have undertaken and the commitment they have shown throughout the program.”

Dr. Mark O’Brien said: “This graduation represents an important milestone for Dubai Health and Oxford Saïd Business School, reflecting a shared commitment to developing leaders who can drive transformation. Their progress throughout the program has been remarkable, and the capabilities they have developed will support Dubai’s continued pursuit of excellence and innovation for many years ahead.”

The Dubai Health Leadership Academy was launched in September 2024, alongside its inaugural Systems Leadership Program, delivered through a partnership with Saïd Business School at the University of Oxford, with the aim of cultivating leadership talent capable of contributing to the advancement of the healthcare sector. It was designed based on the expertise of academics and specialists from around the world, alongside best practices, and was developed in alignment with the priorities and initiatives of Dubai Health, which served as a cornerstone for learning throughout the duration of the program.

Over 14 months, delivered through four modules, participants applied their learning in practice, supported by personalised executive coaching and insights from experts at Oxford Saïd Business School.

A delegation from the Dubai Sports Council visited Al Jalila Foundation, the philanthropic arm of Dubai Health, to learn about its sports philanthropy initiatives and discuss areas of collaboration. 

The delegation was led by His Excellency Khalfan Juma Belhoul, accompanied by His Excellency Saeed Hareb, Secretary General of Dubai Sports Council, and other officials. They were welcomed by His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences; Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences; Dr. Mohamed Al Awadhi, Executive Director of the Dubai Health Women and Children’s Campus; Khalifa Baqer, Chief Operating Officer at Dubai Health, and Shamma Alrafi, Director of Fundraising and Community Engagement Programs at Al Jalila Foundation.

During the visit, His Excellency Khalfan Juma Belhoul learned about Al Jalila Foundation’s sports philanthropy initiatives and met with the Foundation’s “Champions of Hope” team, a group of athletes who leverage sports for humanitarian giving.
To date, the philanthropic sports initiatives have raised AED 15 million through more than 450 community and partner-led activities, with 100% of proceeds directly supporting Al Jalila Foundation’s programs. 
His Excellency Khalfan Juma Belhoul, said: “The Dubai Sports Council is committed to supporting all national efforts and charitable initiatives that aim to enhance the wellbeing, health, and active lifestyles of our community. We see this commitment embodied in the ‘Champions of Hope’ initiative, an inspiring model that harnesses the power of sport and the positive influence of athletes to spread values of generosity and compassion across the community.
His Excellency Dr. Amer Sharif said: “We are honored to welcome His Excellency Khalfan Juma Belhoul and the accompanying delegation, whose visit reflects our commitment to Advancing Health for Humanity.”
He added: “We deeply appreciate the Dubai Sports Council and the athletes, whose dedication and spirit inspire a culture of giving and create a meaningful impact on the community.”

His Excellency Khalfan Juma Belhoul met the “Champions of Hope” team, which included several inspiring athletes: Yahya Al Ghassani, UAE National Football Team player and founder of YA10 Academy; Ghani Souleymane, endurance athlete and Guinness World Record holder for the T100x100 challenge; Mustafa Kaan Yildiz, swimmer and junior coach at Heroes of Hope; Coach Dan Cordero, endurance cyclist and founder of LifeSpark Cycling; Keisha Pais, open-water swimmer who completed the 15-kilometer Bonifacio Strait swim from Italy to France; Ahmed El-Shennawy, member of the inaugural Team Al Jalila Kilimanjaro charity climb and leader of the Himalayan Charity Challenge; Essam Adams, the founder of “Run 4 A Purpose” running club; and Aarti Shah, an Athlete of Determination and member of Heroes of Hope.
 
The visit also featured the signing of a memorandum of understanding (MoU) with YA10 Academy, a sports academy founded by professional Emirati footballer Yahya Al Ghassani that supports emerging football talent. 

Yahya Al Ghassani said: “Through this partnership, YA10 Academy and Al Jalila Foundation will unite sports with philanthropy through athlete engagement and community challenges designed to raise awareness and funds for patient care. It embeds a culture of giving into the academy’s calendar, transforming every training session, match, and milestone into an opportunity for fans to support life-changing healthcare programs”.

Shamma Alrafi said: “For over a decade, we have seen how sports can go beyond the game to drive real change. By combining athletic spirit with charitable initiatives, we can support 
patients in need and inspire the community, showing how Dubai leads in using sports as a force for good.”

Dubai Health has announced the launch of 24-hour operations at Al Lusaily Health Center, starting January 1, 2026. The step came in response to feedback from community members during the “Dubai Health Majalis: Voice of the Community” initiative, which provides a platform for residents to engage directly in shaping healthcare services.

This expansion enhances Dubai Health’s network of around-the-clock health centers, improving access to healthcare services and strengthening the overall readiness of the healthcare system.

Dubai Health currently operates 14 ambulatory health centers across the city, providing a comprehensive range of primary healthcare services for all age groups. These centers offer multidisciplinary services, including preventive care, routine screenings, and the management of chronic conditions.

Khalifa Baqer, Chief Operating Officer at Dubai Health, said: “The transition to round-the-clock operations at Al Lusaily Health Center forms part of a broader set of initiatives driven by community feedback gathered through the Dubai Health Majalis. This initiative was launched in alignment with the Year of Community 2025 and reflects our commitment to putting community feedback into action while ensuring the continuity and advancement of our healthcare service delivery.”
 

He added: “During the year, Dubai Health organized five community Majalis across different areas of Dubai, including Umm Suqeim, Al Khawaneej, Dubai Club for People of Determination, Al Rashidiya, and Al Lusaily, as part of our ongoing efforts to listen to and engage with the community.”

Dr. Ayesha AlBasti, Chair of Family Medicine at Dubai Health, said: “Operating Al Lusaily Health Center around the clock demonstrates our dedication to expanding accessible primary healthcare for the community, actively addressing the needs of Dubai residents. With this step, Al Lusaily Health Center will join the Nad Al Hamar, Al Barsha, and Dubai Airports medical centers, which also operate around the clock. The center will provide integrated medical care across several specialties, including family medicine and emergency care.”

Dubai Health Majalis

Dubai Health launched the “Dubai Health Majalis: Voice of the Community” initiative in support of the objectives of the Year of Community 2025. These engagements are designed to bring Dubai’s residents and the Dubai Health team together in direct conversation through scheduled gatherings in residential neighborhoods. The initiative encourages community members to share feedback, raise concerns, and offer suggestions, empowering them to play an active role in shaping the future of healthcare and services provided by Dubai Health.

Dubai Health announced the successful completion of 234 kidney transplant surgeries since the launch of its kidney transplant programme in 2016, achieving a success rate of over 95 percent and highlighting the impact of cross-sector collaboration.

Dubai Health’s kidney transplant programme is delivered in cooperation with federal, local, and private-sector partners, including the Ministry of Health and Prevention, Dubai Health Authority, Dubai Healthcare City Authority, Dubai Airports, Dubai Corporation for Ambulance Services, the General Directorate of Identity and Foreigners Affairs in Dubai, Dubai Customs, the Dubai Police General Command, Dubai Public Prosecution, and Mediclinic City Hospital, alongside other private healthcare partners. This initiative supports the national Hayat Program for Donation and Transplantation of Human Organs and Tissue, enabling access to life-saving treatments.

Since its inception, the programme has facilitated 234 transplants for patients of diverse nationalities, with children accounting for 31.2 percent of recipients. Of these procedures, 120 were performed at Dubai Health hospitals, 90 at Mediclinic City Hospital, and 24 at Al Qassimi Hospital.

His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), said: “These efforts highlight a collaborative approach across sectors in organ transplantation and reaffirm our commitment to delivering specialised care. They also embody our leadership’s vision of placing human health at the forefront of priorities, reinforcing Dubai’s position in the field.”

Dr. Sharif added: “Guided by our ‘Patient First’ promise, we are committed to ensuring that every patient is given access to comprehensive treatment. This approach reflects a model of care and giving, where the programmes of Al Jalila Foundation, the philanthropic arm of Dubai Health, play a vital role in contributing to a better quality of life.”
The transplant recipients included patients of all ages, with kidneys donated by both living and deceased donors, reflecting growing community awareness of the life-saving importance of organ donation.

Multidisciplinary care

All transplant procedures at Dubai Health are delivered through coordinated, multidisciplinary care aligned with the highest standards and supported by comprehensive assessment, surgical treatment, and structured long-term follow-up.

Al Jalila Foundation supports patients through a range of healthcare programmes, including its ‘Your Donation Saves Lives’ initiative, which encourages organ donation and helps fund transplant treatment. To date, the programme has covered the treatment costs of 66 patients, representing 31.4 percent of all transplant patients in Dubai. In addition, the ‘A’awen’ programme provides essential support for patients who are unable to access or afford specialised care. Together, these initiatives showcase Dubai Health’s commitment to advancing health for humanity.

Dubai Health provides specialised care for patients with kidney failure across its facilities, including Dubai Hospital, Al Jalila Children’s Hospital, Al Twar Dialysis Center, and Al Barsha Dialysis Center.

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, has introduced new nursing education programs through the Hind Bint Maktoum College of Nursing and Midwifery (HBMCoNM).  The expansion aims to advance medical education and align with global standards in this vital field.

Dr. Hanan Al Suwaidi, Deputy Chief Executive Officer and Chief Academic Officer at Dubai Health, and Provost of MBRU, said: “Developing highly skilled nursing professionals is essential to strengthening national healthcare capacity. Through the Hind Bint Maktoum College of Nursing and Midwifery, MBRU is expanding the academic pathways that prepare nurses to contribute to vital roles across the healthcare system ".

Expanded Academic Pathways in Nursing

MBRU’s nursing education pathways now span from undergraduate study to specialized academic training, beginning with the newly introduced Bachelor of Science in Nursing (BSN). Building on this foundation, students can specialize through a Master’s, Postgraduate Diploma, or Postgraduate Certificate in four fields: Cardiovascular Nursing, Critical Care Nursing, Emergency Care Nursing, and Paediatric Nursing. Together, these offerings provide a comprehensive academic route for nurses seeking to build advanced clinical expertise.

Professor Nezam Al Nsair, Dean of the Hind Bint Maktoum College of Nursing and Midwifery, said: “Our expanded academic offerings provide clear, structured pathways for nurses to build advanced clinical competencies. By integrating specialized postgraduate options with strong foundations in clinical training, we are ensuring that graduates are ready to contribute effectively from day one. This approach enhances workforce readiness and supports the continued development of a high-performing nursing profession.”

In addition to the academic offerings at HBMCoNM, the College of Medicine at MBRU continues to offer a range of advanced academic degrees, including a six-year undergraduate Doctor of Medicine program, a four-year undergraduate Graduate Entry Doctor of Medicine program, a Master of Science and PhD in Biomedical Sciences, and a Master’s and Postgraduate Diploma in Health Professions Education. The Hamdan Bin Mohammed College of Dental Medicine offers five postgraduate programs in Endodontics, Prosthodontics, Periodontology, Pediatric Dentistry, and Orthodontics.

At MBRU, students have access to Dubai Health’s research facilities and receive hands-on clinical training in its hospitals, ensuring their education is closely linked to real-world healthcare practice, and high standards of patient care.

To Know more about the MBRU's programs, visit https://www.mbru.ac.ae/.

Dubai Health announced that its Genomic Medicine Center (GMC) has earned accreditation from the College of American Pathologists (CAP), the globally-recognized authority in laboratory quality assurance, marking a significant milestone that reflects its commitment to the highest global standards of quality, accuracy, and safety.

This accreditation is awarded following a precise evaluation conducted by a panel of experts to verify laboratories’ compliance with internationally recognized standards in the field. It is considered one of the world’s leading medical laboratory quality assurance programs, aimed at achieving the highest levels of excellence in laboratory practices.

Dr. Ahmad Abou Tayoun, Director of the Genomic Medicine Center at Dubai Health, expressed his profound pride in the center’s achievement in obtaining accreditation from the College of American Pathologists (CAP), a milestone that reflects Dubai Health’s commitment to the highest internationally recognized quality standards and its dedication to providing high-quality services to patients and physicians. He added that this recognition further strengthens the center’s position as a leading hub for genomic medicine and advanced research.

Dr. Abou Tayoun further explained that Dubai Health’s Genomic Medicine Center supports the overall healthcare system, from analyzing genomic data to providing consultation and follow-up for individuals and families. This approach enables medical professionals to make precise, evidence-based treatment decisions. The center also provides a comprehensive range of genetic tests and analyses through its molecular genetics, genomics, and cytogenetics laboratories, including genetic diagnosis of heredity conditions and rare diseases and the premarital genetic screening program. The center contributes to supporting public health programs in the UAE.”

The Genomic Medicine Center also supports Dubai Health’s integrated academic health system model, as it is consisted of a team of physicians and researchers alongside students from Mohammed Bin Rashid University of Medicine and Health Sciences, the arm of learning and discovery of Dubai Health. This collaboration aims to transform biomedical discoveries into practical solutions that contribute to advancing healthcare services.

Dr. Mohamed Al Awadhi: More than 60 patients have successfully completed their treatment since the launch of the pediatric oncology unit in April 2023.

Dubai, United Arab Emirates, XX December 2025: Dubai Health’s Al Jalila Children’s Hospital celebrated an inspiring moment as five-year-old Alexis O’Shea rang the hospital’s “Bell of Hope,” marking the end of her treatment and the beginning of a brighter chapter ahead. The ceremony, the hospital’s first, symbolizes the completion of a child’s cancer journey and the start of recovery filled with renewed strength and optimism.

This milestone moment crowned a nine-month treatment journey that began when Alexis was diagnosed with an advanced Wilms tumor that had spread to her lungs. She underwent an intensive and expertly coordinated treatment plan that included chemotherapy, surgery, and radiotherapy, overseen by a multidisciplinary team of pediatric surgeons, oncologists, therapists, nurses, and child-life specialists.

Dr. Mohamed Al Awadhi, Executive Director of the Women and Children’s Campus at Dubai Health, said: “Alexis’s recovery reflects Dubai Health’s commitment to delivering child-centered, integrated care that addresses medical, emotional, and social needs. Her journey highlights the essential role of multidisciplinary coordination, where expertise, compassion, and our ‘Patient First’ promise come together at every stage of treatment.”

He added that Dubai Health remains dedicated to advancing the quality of pediatric care through comprehensive clinical, rehabilitative, and psychosocial programs that support patients and their families from diagnosis to full recovery. Since the launch of the pediatric oncology unit in April 2023, more than 60 patients have successfully completed their treatment, a reflection of the care teams’ dedication and the growing impact of these services.

Dr. Dermot Murphy, Consultant Pediatric Oncologist at Dubai Health, said: “Alexis’s story is one of hope, courage, and determination. Her progress reminds us that with the right care, the right support, and a united team, children can overcome even the most challenging diagnoses.”

He continued: “Her treatment brought together a team of specialists working in close coordination to ensure she received the highest level of care. For us, it was never just about treating an illness, it was about caring for a young girl and supporting her family every step of the way. When the child comes first, every decision becomes more meaningful.”

Alexis’s mother, Jill DeMello, expressed her gratitude and joy, saying: “The sound of the bell is a moment we will never forget. It marks a new beginning, one filled with hope and possibility. We are deeply thankful to the incredible team at Al Jalila Children’s Hospital, who supported us throughout this journey and gave us strength when we needed it most.”

The “Ring the Bell” tradition, adopted by many hospitals around the world, has become a powerful symbol of triumph over cancer. For children, their families, and the care teams who walk alongside them, it represents happiness, and the promise of a new chapter.

The conference featured a series of scientific discussions, presentations, and workshops focused on research to improve health outcomes.

Dubai, UAE 10 December 2025: Dubai Health successfully convened the second edition of the Dubai Health Research Conference 2025. The event brought together physicians, experts, and academics to present the latest in medical research, reinforcing Dubai’s position in advancing scientific research.

His Excellency Dr. Alawi Alsheikh-Ali, Director General of the Dubai Health Authority, attended the conference and honored researchers recognized in the “Best Oral Presentation” and “Best Research Poster” categories. The event was also attended by Professor Ian Bruce, Pro-Vice-Chancellor for the Faculty of Medicine, Health and Life Sciences at Queen's University Belfast, and His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).

Held over three days at Mohammed Bin Rashid University of Medicine and Health Sciences, the conference featured a series of scientific discussions, presentations, and workshops focused on research to improve health outcomes.

The conference aimed to provide a platform for showcasing pioneering medical advancements and enhancing networking opportunities among researchers and healthcare specialists. It sought to support knowledge exchange through productive scientific dialogue and contribute to the professional development of physicians and healthcare professionals via workshops, seminars, and keynote presentations designed to expand expertise.

Professor Stefan Du Plessis, Dean of Research and Graduate Studies at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), said: "The Dubai Health Research Conference 2025 demonstrates our commitment to creating an environment where research can flourish. It offers our clinicians, scientists, and trainees a platform to exchange knowledge and contribute to work that ultimately benefits our patients and community.”

Dr. Hamda Khansaheb, Director of Research Administration and Support at MBRU, stated: “The conference underscores our commitment to advancing an integrated culture of research and discovery across Dubai Health. By bringing together researchers, clinicians, and trainees, we are creating pathways that enable evidence-based discovery and contribute to improved patient outcomes. The breadth and quality of the work presented this year demonstrate the growing capability of our community and its dedication to advancing health for humanity.”

International Scientific Contributions

The conference featured distinguished international speakers who presented advanced scientific contributions. Professor Andrew Beggs, Professor of Cancer Genetics and Surgery in the Department of Cancer and Genomic Sciences at the University of Birmingham in the United Kingdom highlighted methods of developing precision medicine. Professor Manuel Salto-Tellez, Professor of Molecular Pathology at Queen’s University Belfast, explored the applications of personalized medicine in oncology.

The event also showcased the latest scientific research across Dubai Health’s integrated academic health system, connecting researchers, professionals, and trainees to improve clinical outcomes. Presentations highlighted clinical research in genomic medicine, digital health, artificial intelligence, microbiome science, and women’s health.

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Chairman of Dubai's Supreme Committee of Crisis and Disaster Management, and Vice Chairman of Dubai Health’s Board of Directors, has reaffirmed that blood donation is a humanitarian duty and a national responsibility that reflects the noble values of the UAE.

His Highness Sheikh Mansoor said: “The ‘My Blood, for My Country’ campaign serves as an inspiring model for meaningful community partnerships that strengthen our healthcare system. The growing awareness around the importance of blood donation demonstrates that the culture of giving has become an integral part of our society. We encourage all members of our community to participate in the campaign and amplify its life-saving impact.”

His Highness made these remarks as he donated blood at the Dubai Health Blood Donation Center, personally demonstrating his support of voluntary blood donation.

His Highness Sheikh Mansoor was received upon arrival by His Excellency Dr. Alawi Alsheikh-Ali, Director General of the Dubai Health Authority; His Excellency Lieutenant General Awad Hader Al Muhairi, Vice President of Dubai's State Security Department; His Excellency Major General Tamim Mohammed Al Muhairi, Director General of Dubai's State Security Department; and His Excellency Dr. Amer Sharif, CEO of Dubai Health.

Organised in partnership with Al Ameen Service, the Dubai Health Authority (DHA), Dubai Health, and Emarat Al Youm newspaper, the campaign aims to provide blood units for patients, ensure sufficient supplies for the Thalassemia Center, and promote a culture of voluntary blood donation.

His Excellency Dr. Alawi Alsheikh-Ali, said: “The participation of His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum reflects his continued support for health and community initiatives and his commitment to encouraging blood donation. Donating blood is an important humanitarian act that contributes to saving patients’ lives, and community engagement with the campaign demonstrates growing awareness of national health initiatives.”

His Excellency also reaffirmed DHA’s commitment to strengthening the voluntary blood donation system and supporting programmes that enhance healthcare readiness.

His Excellency Dr. Amer Sharif expressed his gratitude for His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum’s support to the campaign. Dr. Sharif said: “His Highness’s leadership inspires a culture of giving, encouraging both individuals and organisations to participate in this national initiative. Dubai Health is committed to raising awareness on the importance of regular blood donation and expanding the campaign’s humanitarian impact.”

Strengthening community solidarity
Omar Al Falasi, General Supervisor of Al Ameen Service, reaffirmed that the ‘My Blood, for My Country’ campaign continues to strengthen the spirit of solidarity in the community through its messages of giving, humanitarian action, and encouraging community-led initiatives.

He said: “For more than a decade, this campaign has delivered positive outcomes for society. It has been essential for both donors and patients, contributing to disease prevention and advancing public health in the UAE. Al Ameen Service remains committed to supporting efforts that protect the safety and well-being of the community.”

Ibrahim Shukrallah, Editor-in-Chief of Emarat Al Youm, said that the blood donation made by His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum represents an inspiring model of humanitarian action. “Our partnership in this campaign stems from a deep sense of social responsibility. We are committed to raising awareness and promoting blood donation as a life-saving humanitarian act.”

The ‘My Blood, for My Country’ campaign seeks to attract new, particularly first-time, blood donors to expand the Donation Center’s database, especially among individuals with rare blood types. The campaign also focuses on encouraging young people aged 18 to 30 to donate, promoting blood donation as part of a healthy lifestyle. The campaign also encourages both government and private entities to participate in blood donation drives, fostering a culture of giving, and building an inclusive and supportive community network.

- Mansoor bin Mohammed congratulates Al Jalila Children’s Hospital for No. 1 regional ranking in Newsweek’s Best Specialized Hospitals 2026 list

His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors, met with a team representing Al Jalila Children’s Hospital to celebrate its achievement after it was named the top-ranked paediatric hospital in the Middle East, according to Newsweek’s Best Specialized Hospitals 2026.

The meeting was held at the headquarters of Dubai Health in the presence of members of the Dubai Health Board of Directors including His Excellency Abdullah Abdulrahman Al Shaibani, His Excellency Walid Saeed Al Awadhi, His Excellency Mohammed Hassan Al Shehhi, Dr. Amer Sharif, and Dr. Hanan Al Suwaidi. Also in attendance were Dr. Abdullah Al Khayat, CEO Emeritus of Al Jalila Children’s Hospital; Dr. Mohammed Al Awadhi, Executive Director of the Women and Children’s Health Campus; and Dr. Ibrar Majeed, Chair of Paediatrics, along with several department directors, consultants, and heads of paediatric specialties. 

His Highness, together with members of the Dubai Health Board of Directors, reviewed the rankings issued by Newsweek’s Best Specialized Hospitals Middle East 2026. In addition to Al Jalila Children’s Hospital being recognised as the top specialised paediatric hospital, Rashid Hospital was ranked third in Orthopaedics in the Middle East.
His Highness stated: “This achievement reflects Dubai’s position as a global hub for advanced healthcare and the strength of our system in providing exceptional outcomes. We commend the dedication of all teams across Dubai Health for their role in advancing health for humanity.”

The Newsweek rankings are based on a rigorous methodology developed with Statista, incorporating patient-reported outcomes, satisfaction scores, peer recommendations, and international accreditations, making them a trusted benchmark for healthcare excellence worldwide.

Dr. Amer Sharif, CEO of Dubai Health, expressed gratitude for the continued support of His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors; His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum; and members of the Dubai Health Board of Directors for their continued support to strengthen Dubai’s leading position in healthcare. “We are proud to see Al Jalila Children’s Hospital recognised as the region’s leader in paediatric care. This milestone reflects the tireless efforts of our teams to deliver care aligned with global standards,” he said.

Dr. Mohammed Al Awadhi said: “We extend our heartfelt gratitude to His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum for meeting with the Al Jalila Children’s team and inspiring our continued pursuit of excellence.

“We deeply value the feedback from our patients, which played a pivotal role in achieving this prestigious ranking. It reflects our unwavering commitment to delivering a comprehensive and world-class model of paediatric care across all specialties.”

55 participants received accredited certificates and completed 35.5 hours of training

Dubai- UAE, 00 November 2025:

Dubai Health organized a specialized training program, Essential Skills in Organ Donation, to enhance the capabilities of healthcare professionals involved in organ donation and transplantation, ensuring alignment with global medical standards.

Endorsed by the Ministry of Health and Prevention, the Department of Health Abu Dhabi, and Dubai Health Authority, participants earned a professional certificate from Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, in addition to 35.5 credit hours in continuing medical education (CME) accredited by the Dubai Health Authority. A total of 55 physicians, nurses, technicians, and organ donation coordinators from across the UAE took part in the program.

The two-day program, held at MBRU, was attended by His Excellency Dr. Rashed Obaid Al Suwaidi, Director General of the Abu Dhabi Public Health Center; His Excellency Dr. Ali Abdulkarim Al Obaidli, Chairman of the UAE National Committee for Organ Donation and Transplantation;  Dr. Maria Gomez, Director of the National Centre for Donation and Transplantation of Human Organs and Tissues; Dr. Hanan Obaid, Director of Health Policies and Standards Department at the Dubai Health Authority.

Representing Dubai Health at the program’s launch ceremony were His Excellency Dr. Amer Sharif, CEO of Dubai Health and President of MBRU; Dr. Hanan AlSuwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of MBRU; Dr. Tarek Fathey, Chief Clinical Officer of Dubai Health; Nujood Al Khloofi, Senior Director of Organ Donation and Transplantation Program at Dubai Health; and Rasha Buhumaid, Dean of Graduate Medical Education and the College of Medicine at MBRU.

H.E. Dr. Amer Sharif said: “Dubai Health is committed to supporting organ donation and transplantation in the UAE. This includes advancing the professional development of our healthcare professionals within our integrated academic health system, and contributing towards national efforts that enhance services in this area.”

He added, “We are grateful to contribute towards impactful programs that promote the culture of organ donation as a noble humanitarian act that saves lives. Working alongside our partners strengthens our collective efforts, and we look forward to continuing these efforts that support progress in this field of healthcare.”

Specialized Program

The specialized program took place at MBRU’s Khalaf Ahmad Al Habtoor Medical Simulation Center, where participants engaged in realistic scenarios that reflected real-life situations. The hands-on approach allowed them to practice their roles, strengthening their readiness and improving their skills in managing organ donation cases with confidence and professionalism.

The program also included a series of theoretical sessions and practical workshops that provided comprehensive training on the essentials of human organ donation, aligned with the latest global practices in the field.

The training program was presented by specialists in critical care from the National Center for Organ Donation and Transplantation, Emirates Health Services, The Ministry of Presidential Affairs Medical Office, SEHA- Abu Dhabi Health Services Company, Cleveland Clinic Abu Dhabi, and Dubai Health. It primarily targeted licensed healthcare practitioners, including physicians, nurses, and allied health technicians, particularly those working in intensive care, emergency medicine, neurology, and internal medicine.

The program, the first-of-its-kind in the UAE within an integrated academic health system, aligns with the Dubai Health Authority’s mandate to train 70% of intensive care and relevant teams in essential organ donation skills.

Inspiring stories

Two families with inspiring experiences in organ donation shared their stories with the participants. Emirati father, Hamdan Al Mulla, spoke about donating his kidney to save the life of his nine-year-old son, Rashid. The surgery performed at Rashid Hospital in Dubai, has allowed his son to regain his health and improve his quality of life.
 A French resident, Nathalie Groll, also recounted her humanitarian experience, describing her decision to donate the organs of her deceased son, Vego, which helped save the lives of five people.

Ongoing efforts

Dubai Health continues to lead organ donation efforts across the UAE, where it has successfully facilitated more than 280 transplant procedures across its facilities, all made possible by the generous support of more than 90 donor families. The organization remains committed to supporting the goals of the UAE’s National Program for Organ and Tissue Donation and Transplantation, Hayat, by providing specialised care programs, advancing scientific research, and assisting patients who are unable to afford treatment costs. These efforts have contributed significantly to promoting a culture of organ donation and raising community awareness surrounding its profound humanitarian impact.